For example, a study that focused on the clinical validation of a serum protein panel consisting of FLNA, FLNB, and KRT19 (keratin 19) found that their expression and PSA in combination were better than PSA alone in identifying prostate cancer. The gene discussed is KRT19; the disease is Familial prostate cancer.